Interpace Biosciences, Inc. Stock
Stocks
IDXG
US46062X3035
Healthcare Facilities & Services
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.500 USD | -8.54% |
|
-7.98% | +21.93% |
| Market Cap | 41.55M 36.51M 33.85M 31.13M 58.81M 3.97B 60.08M 404M 158M 1.95B 156M 153M 6.75B | P/E 2024 |
6.84x | P/E 2025 | 1.39x |
|---|---|---|---|---|---|
| Enterprise Value | 40.23M 35.35M 32.77M 30.14M 56.94M 3.85B 58.17M 391M 153M 1.89B 151M 148M 6.53B | EV / Sales 2024 |
0.35x | EV / Sales 2025 | 0.11x |
| Free-Float |
14.74% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -8.54% | ||
| 1 week | -7.98% | ||
| Current month | -7.98% | ||
| 1 month | -6.25% | ||
| 3 months | -34.78% | ||
| 6 months | +24.48% | ||
| Current year | +21.93% |
| 1 week | 1.47 | 1.65 | |
| 1 month | 1.47 | 1.8 | |
| Current year | 1.03 | 2.4 | |
| 1 year | 0.76 | 2.4 | |
| 3 years | 0.44 | 3.54 | |
| 5 years | 0.44 | 10.5 | |
| 10 years | 0.44 | 198 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Burnell
CEO | Chief Executive Officer | 63 | 2020-11-30 |
| Director of Finance/CFO | 34 | 2023-04-20 | |
Nicole Massoll
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Sullivan
CHM | Chairman | 78 | 2016-06-20 |
Joseph Keegan
BRD | Director/Board Member | 73 | 2015-12-31 |
Fortunato Rocca
BRD | Director/Board Member | 64 | 2020-01-21 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| Jan. 19 | 1315 Capital LLC
| Conversion | Company | 9,405,941 | 212.3938% | |
| Jan. 19 | Ampersand Management LLC
| Conversion | Company | 13,861,386 | 313.0013% | |
| 24-01-31 | Free | Chief Financial Officer | 10,000 | 0.2314% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -8.54% | -7.98% | +86.52% | -32.43% | 45.43M | ||
| +1.09% | -2.30% | +70.10% | +433.82% | 38.66B | ||
| -0.05% | -3.59% | +10.84% | +29.85% | 22.7B | ||
| -1.46% | -1.51% | -23.11% | -39.58% | 7.3B | ||
| -3.49% | -7.91% | +14.11% | +104.49% | 5.16B | ||
| +1.91% | +4.82% | +17.90% | +44.90% | 2.97B | ||
| -2.73% | -5.42% | -22.66% | +800.56% | 1.95B | ||
| -1.17% | 0.00% | +33.47% | -19.89% | 1.84B | ||
| 0.00% | -6.93% | +94.35% | -16.80% | 1.84B | ||
| +4.87% | +3.19% | +25.58% | +4.06% | 1.75B | ||
| Average | -0.96% | -0.51% | +30.71% | +130.90% | 8.42B | |
| Weighted average by Cap. | +0.22% | -2.62% | +37.44% | +229.57% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 46.93M 41.23M 38.23M 35.16M 66.41M 4.49B 67.85M 456M 178M 2.2B 176M 172M 7.62B | 38.73M 34.03M 31.55M 29.01M 54.81M 3.7B 56M 376M 147M 1.82B 145M 142M 6.29B |
| Net income | 6.7M 5.89M 5.46M 5.02M 9.49M 641M 9.69M 65.09M 25.49M 315M 25.16M 24.61M 1.09B | 24.58M 21.59M 20.02M 18.41M 34.78M 2.35B 35.53M 239M 93.45M 1.15B 92.27M 90.25M 3.99B |
| Net Debt | 4.4M 3.86M 3.58M 3.29M 6.22M 420M 6.35M 42.68M 16.71M 207M 16.5M 16.14M 714M | -1.32M -1.16M -1.08M -990K -1.87M -126M -1.91M -12.84M -5.03M -62.12M -4.96M -4.86M -215M |
Employees
102
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-13 | $1.500 | -8.54% | 3,221 |
| 26-07-10 | $1.640 | +0.11% | 4,640 |
| 26-07-09 | $1.638 | +0.81% | 673 |
| 26-07-08 | $1.625 | -1.22% | 550 |
| 26-07-07 | $1.645 | -0.30% | 1,281 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- IDXG Stock
Select your edition
All financial news and data tailored to specific country editions
















